Related Experiment Videos

Inflammatory Cytokine Dysregulation and Interleukin Gene Polymorphisms in Iraqi Pediatric Sickle Cell Anemia:

Sundus K Hamzah1, Wisam H Hoidy1

  • 1Department of Chemistry, College of Education, University of Al-Qadisiyah, Al-Diwanyah City, Iraq.

Pediatric Blood & Cancer
|July 23, 2026
PubMed

Insights

This study reveals significant inflammatory dysregulation and interleukin gene variations in Iraqi children with sickle cell anemia (SCA). These findings support cytokines as biomarkers and highlight potential for anti-inflammatory therapies in SCA management.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Sickle cell anemia (SCA) is characterized by inflammation, exacerbating symptoms and complications.
  • Inflammatory profiles and genetic factors in pediatric SCA patients in Iraq are poorly understood.
  • This study investigates cytokine dysregulation and interleukin gene polymorphism in Iraqi pediatric SCA patients.

Purpose of the Study:

  • To analyze cytokine dysregulation in pediatric SCA patients in Iraq.
  • To investigate interleukin gene polymorphism associated with SCA in the Iraqi pediatric population.
  • To explore the diagnostic value of specific interleukins as biomarkers for SCA.

Main Methods:

  • A case-control study involving 216 pediatric SCA patients and 330 healthy controls.
  • Quantification of serum Interleukin (IL)-1β, IL-2, IL-4, IL-8, IL-10, and IL-17 levels using ELISA.
  • Analysis of gene polymorphisms for IL-1β, IL-2, IL-4, IL-8, IL-10, and IL-17.

Main Results:

  • Significant associations found between IL-10 -1082 G/A and IL-17 -197 G/A polymorphisms and SCA status.
  • Increased frequency of IL-10 -1082 A allele and IL-17 -197 A allele carriers in SCA patients.
  • High diagnostic value for IL-8 (AUC=0.958) and IL-17 (AUC=0.946); IL-17 levels correlated with vaso-occlusive crises (r=0.623).

Conclusions:

  • Evidence of significant inflammatory dysregulation and genetic associations in pediatric SCA in Iraq.
  • Cytokines show potential as reliable biomarkers for SCA.
  • Supports the development of targeted anti-inflammatory therapies for pediatric SCA.
Abstract

Keywords:
Iraqi childrenTetra‐ARMS PCRinflammatory cytokinesinterleukinssickle cell anemia

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.